Evidence map›Paper›PMID 36535168›Full record

ArticleJournal of colloid and interface science2023

"Non-cytotoxic" doses of metal-organic framework nanoparticles increase endothelial permeability by inducing actin reorganization.

Jinyuan Liu, Alex Rickel, Steve Smith, Zhongkui Hong, Congzhou Wang

Open access · greenAbstract read
In one paragraph

Article in Journal of colloid and interface science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Metal-Organic Frameworks: Unlocking New Frontiers in Cardiovascular Diagnosis and Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jinyuan LiuNanoscience and Nanoengineering, South Dakota School of Mines and Technology, 501 East Saint Joseph Street, Rapid City, SD 57701, USA; BioSystems, Networks & Translational Research (BioSNTR), 501 East Saint Joseph Street, Rapid City, SD 57701, USA.
Alex RickelBiomedical Engineering, University of South Dakota, 4800 N Career Avenue, Sioux Falls, SD 57107, USA; BioSystems, Networks & Translational Research (BioSNTR), 501 East Saint Joseph Street, Rapid City, SD 57701, USA.
Steve SmithNanoscience and Nanoengineering, South Dakota School of Mines and Technology, 501 East Saint Joseph Street, Rapid City, SD 57701, USA; BioSystems, Networks & Translational Research (BioSNTR), 501 East Saint Joseph Street, Rapid City, SD 57701, USA.
Zhongkui HongBiomedical Engineering, University of South Dakota, 4800 N Career Avenue, Sioux Falls, SD 57107, USA; BioSystems, Networks & Translational Research (BioSNTR), 501 East Saint Joseph Street, Rapid City, SD 57701, USA; Mechanical Engineering, Texas Tech University, 805 Boston Ave, Lubbock, TX 79409, USA. Electronic address: zhongkui.hong@ttu.edu.
Congzhou WangNanoscience and Nanoengineering, South Dakota School of Mines and Technology, 501 East Saint Joseph Street, Rapid City, SD 57701, USA; BioSystems, Networks & Translational Research (BioSNTR), 501 East Saint Joseph Street, Rapid City, SD 57701, USA. Electronic address: congzhou.wang@sdsmt.edu.
South Dakota School of Mines and Technology · USTexas Tech University · USUniversity of South Dakota · US

Funding

Mechanical Response and Cytoskeletal Rearrangement Following Interrupted Cholesterol Metabolism in Vascular Smooth Muscle CellR15HL147214 · NHLBI · UNIVERSITY OF SOUTH DAKOTA · PI HONG, ZHONGKUI · 2020 to 2020
$429k
Metal-organic Framework Encapsulation of Biomolecules for Ultra-stable Diagnostic Assays and Sensors in Resource-limited SettingsR03EB028869 · NIBIB · SOUTH DAKOTA SCHOOL OF MINES AND TECHN'Y · PI WANG, CONGZHOU · 2020 to 2021
$130k
NHLBI NIH HHS R15 HL147214NIBIB NIH HHS R03 EB028869
6 · The paper itself

Abstract

Cytotoxicity of nanoparticles is routinely characterized by biochemical assays such as cell viability and membrane integrity assays. However, these approaches overlook cellular biophysical properties including changes in the actin cytoskeleton, cell stiffness, and cell morphology, particularly when cells are exposed to "non-cytotoxic" doses of nanoparticles. Zeolitic imidazolate framework-8 nanoparticles (ZIF-8 NPs), a member of metal-organic framework family, has received increasing interest in various fields such as environmental and biomedical sciences. ZIF-8 NPs may enter the blood circulation system after unintended oral and inhalational exposure or intended intravenous injection for diagnostic and therapeutic applications, yet the effect of ZIF-8 NPs on vascular endothelial cells is not well understood. Here, the biophysical impact of "non-cytotoxic" dose ZIF-8 NPs on human aortic endothelial cells (HAECs) is investigated. We demonstrate that "non-cytotoxic" doses of ZIF-8 NPs, pre-defined by a series of biochemical assays, can increase the endothelial permeability of HAEC monolayers by causing cell junction disruption and intercellular gap formation, which can be attributed to actin reorganization within adjacent HAECs. Nanomechanical atomic force microscopy and super resolution fluorescence microscopy further confirm that "non-cytotoxic" doses of ZIF-8 NPs change the actin structure and cell morphology of HAECs at the single cell level. Finally, the underlying mechanism of actin reorganization induced by the "non-cytotoxic" dose ZIF-8 NPs is elucidated. Together, this study indicates that the "non-cytotoxic" doses of ZIF-8 NPs, intentionally or unintentionally introduced into blood circulation, may still pose a threat to human health, considering increased endothelial permeability is essential to the progression of a variety of diseases. From a broad view of cytotoxicity evaluation, it is important to consider the biophysical properties of cells, since they can serve as novel and more sensitive markers to assess nanomaterial's cytotoxicity.

Indexed as

Antineoplastic AgentsMetal-Organic FrameworksNanoparticlesZeolitesActinsEndothelial CellsHumansActinsAntineoplastic AgentsMetal-Organic FrameworksZeolitesActin reorganizationEndothelial permeabilityHuman aortic endothelial cellsNon-cytotoxic dosesZeolitic imidazolate framework-8 nanoparticles

Identifiers

PMID36535168
PMCPMC9840705
OpenAlexW4312019142

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.